Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis
Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis
Active, not recruiting · NCT06477406 · Registry updated 2026-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Urogenital Diseases, endometriosis, female reproductive system disorder | Active, not recruiting | Phase 2 | 2026-09-30 | NCT06477406 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Massachusetts Life Sciences Center | 1 |
| Mclean Hospital | 54 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| McLean Hospital | Belmont | United States | 47 |